Sec-O-Glucosylhamaudol Cas No
Bioactivity Sec-O-Glucosylhamaudol
Sec-O-Glucosylhamaudol productum est naturale a Binhai Qianhu remotum, quod potest reducere µ.
Genera pertinentia:
Receptaculum / > G interdum receptor / G interdum > > receptor opioideus
> > > tramitem neurale signum > > tramitem opioideum > >
Investigationes campi > > morbi neurologici
De Proprietatibus Physico- Sec-O-Glucosylhamaudol
Densitas: 1.6 ± 0.1 g / cm3
Fervens punctum: 677.5 ± 55.0 ° C ad 760 mmHg
Formulae hypotheticae: c21h26o10
Pondus hypotheticum: 438,425
Mico punctum: 237.2 ± 25.0 ° C
Exacta massa: 438.152588
PSA: 159.05000
LogP: 0.39
Vapor pressus: 0.0 ± 2.2 mmHg ad 25° C
Index refractivus: 1.661
Anglicus Alias Of Sec-O-Glucosylhamaudol
(3S) -5-hydroxy-2,2,8-trimethyl-6-oxo-3,4-dihydro-2H,6H-pyrano[3,2-g]chromen-3-yl β-D-glucopyranoside, sec. -O-glucosyl hamaudol,2H,6H-Benzo[1,2-b:5,4-b'] dipyran-6-unum, 3-(β-D-glucopyranosyloxy)-3,4-dihydro-hydroxy. -2,2,8-trimethyl-, (3S)-sec-O-Glucosylhamaudol
Turba Profile
Jiangsu Yongjian Pharmaceutical Technologia Co, Ltd, constituta in Martio MMXII, est summus tech incepti integralis R & D, productio et venditio.Maxime versatur in productione, customizatione et processu productionis rerum naturalium productorum activorum, tradito medicinali Sinensi materiae et medicamentorum immunditiis referentibus.Societas Pharmaceutical in Sinis sita, urbs Taizhou, Provincia Jiangsu, cum 5000 quadratum metrorum productio basis et 2000 metrorum quadratorum R & D basis.Maioribus investigationibus scientificis inservit Institutis, universitatibus et decoctionis inceptis productionis in Sinis.
Hactenus, plus quam 1500 genera reorum compositorum naturalium elaboravimus, et plus quam trecentos ex eis comparavimus et calibravimus, quae ad cotidianam inspectionem necessitates maioris investigationis scientificae institutorum, universitatis laboratoriae et decoctionis partium fabricantium plene occurrere possunt.
Ex principio bonae fidei, societas sperat se sincere cooperari cum clientibus nostris.Propositum est nostrae modernizationi traditae Sinicae medicinali inservire.
Commodi Negotia Scopus Societatis
1. R & D, productio et venditio materiae chemicae referentis medicinam traditam Sinensis;
2. customized traditum Seres medicina monomer componit secundum proprietates mos
3. Investigatio de qualitate regulae et processu evolutionis medicinae traditae Sinensi (plantae) extracti
4. Processus technology cooperante et translatio
